<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">21827891</PMID>
      <DateCompleted>
        <Year>2011</Year>
        <Month>12</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2013</Year>
        <Month>03</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0072-9752</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>103</Volume>
            <PubDate>
              <Year>2012</Year>
            </PubDate>
          </JournalIssue>
          <Title>Handbook of clinical neurology</Title>
          <ISOAbbreviation>Handb Clin Neurol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Paraneoplastic cerebellar degeneration.</ArticleTitle>
        <Pagination>
          <StartPage>215</StartPage>
          <EndPage>223</EndPage>
          <MedlinePgn>215-23</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/B978-0-444-51892-7.00013-9</ELocationID>
        <Abstract>
          <AbstractText>One of the most dramatic and devastating examples of a remote effect of cancer is paraneoplastic cerebellar degeneration (PCD). There is convincing evidence that this disorder is caused by autoimmunity directed against cerebellar targets. Typically, the neurological presentation antedates the diagnosis of malignancy, and the cancer, when found, tends to be localized and responsive to treatment. Diagnosis depends on clinical suspicion, serology for paraneoplastic antibodies, and a focused search for cancer. Neuronal autoantibody tests facilitate the diagnosis and help direct the search for malignancy. Unfortunately, even with prompt diagnosis, current treatment strategies meet with limited success. Optimum management includes early diagnosis, treatment of cancer to remission, immunosuppression, symptomatic therapies, and compassionate support.</AbstractText>
          <CopyrightInformation>2012 Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Vernino</LastName>
            <ForeName>Steven</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>University of Texas Southwestern Medical Center, Dallas, TX 75390-9036, USA. steven.vernino@utsouthwestern.edu</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Handb Clin Neurol</MedlineTA>
        <NlmUniqueID>0166161</NlmUniqueID>
        <ISSNLinking>0072-9752</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020362" MajorTopicYN="Y">Paraneoplastic Cerebellar Degeneration</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2011</Year>
          <Month>8</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2011</Year>
          <Month>8</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2011</Year>
          <Month>12</Month>
          <Day>13</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">21827891</ArticleId>
        <ArticleId IdType="doi">10.1016/B978-0-444-51892-7.00013-9</ArticleId>
        <ArticleId IdType="pii">B978-0-444-51892-7.00013-9</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
